ŠIMEČKOVÁ, Hana, Radka OBOŘILOVÁ, Matěj PASTUCHA, Jan PŘIBYL, Petr SKLÁDAL, Roman PANTŮČEK, Ivana MAŠLAŇOVÁ and Zdeněk FARKA. Phage-mediated bacterial lysis studied by AFM and SPR. In Genetická konference GSGM 2022 a XXIX. Genetické dny. 2022. ISBN 978-80-7302-182-5.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Phage-mediated bacterial lysis studied by AFM and SPR
Authors ŠIMEČKOVÁ, Hana (203 Czech Republic, belonging to the institution), Radka OBOŘILOVÁ (203 Czech Republic, belonging to the institution), Matěj PASTUCHA (203 Czech Republic, belonging to the institution), Jan PŘIBYL (203 Czech Republic, belonging to the institution), Petr SKLÁDAL (203 Czech Republic, belonging to the institution), Roman PANTŮČEK (203 Czech Republic, belonging to the institution), Ivana MAŠLAŇOVÁ (203 Czech Republic, belonging to the institution) and Zdeněk FARKA (203 Czech Republic, belonging to the institution).
Edition Genetická konference GSGM 2022 a XXIX. Genetické dny, 2022.
Other information
Original language English
Type of outcome Presentations at conferences
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW Conference pages
RIV identification code RIV/00216224:14310/22:00127124
Organization unit Faculty of Science
ISBN 978-80-7302-182-5
Keywords in English Bacteriophage; Atomic force microscopy; AFM; Surface plasmon resonance; SPR; Staphylococcus aureus; Lysis; Phage therapy
Tags Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 15/3/2023 10:33.
Abstract
Since the emergence and spread of multidrug-resistant bacterial strains exceed the development of new antimicrobial agents, an amount of research aimed at finding new therapeutic approaches is fostering. Suitable alternatives to combat bacterial infections include bacterial viruses (bacteriophages) or lytic enzymes (enzybiotics) as possible replacements or enhancers of conventional antibiotics. Phage therapy uses lytic phages to kill the bacterial host as a result of the virus life cycle, thus working with dynamic, living, and evolving entities. Detailed characterization of phage-mediated bacterial lysis is, therefore, essential. Biosensor-based techniques are sensitive and rapid analytical methods that provide detailed insight into lytic processes. As a surface imaging technique, atomic force microscopy (AFM) can be used to visualize cells and measure their mechanical properties. Biosensors based on surface plasmon resonance (SPR) record the interactions between biomacromolecules or small particles. Both of these approaches allow for monitoring immobilized cells under native conditions and in real-time. In our work, we investigate the effect of lytic antimicrobials against the pathogen Staphylococcus aureus. The study is focused on bacterial lysis mediated by the phage vB_SauP_P68 (P68) and the enzyme lysostaphin. AFM enabled a high-resolution investigation of topographical and biomechanical properties at the single cell level. The SPR experiments completed the work with the information on the kinetics of agent-bacterium interaction. The results are believed to help fight against bacterial infections and support the development of phage therapy.
Links
GA18-13064S, research and development projectName: Analýza interakcí mezi polyvalentním terapeutickým fágem druhu Twort-like a jeho hostitelem Staphylococcus aureus
Investor: Czech Science Foundation
GA21-03156S, research and development projectName: Foton-upkonverzní značky pro mikrofluidní jednomolekulové imunostanovení proteinových biomarkerů
Investor: Czech Science Foundation
LX22NPO5103, research and development projectName: Národní institut virologie a bakteriologie (Acronym: NIVB)
Investor: Ministry of Education, Youth and Sports of the CR, National Institute of Virology and Bacteriology, 5.1 EXCELES
MUNI/A/1325/2021, interní kód MUName: Podpora výzkumné činnosti studentů molekulární biologie a genetiky 10 (Acronym: MBG10)
Investor: Masaryk University
NU22-05-00042, research and development projectName: Vývoj nových nanobiotechnologií pro sledování terapeutických bakteriofágů v klinických vzorcích
Investor: Ministry of Health of the CR, Subprogram 1 - standard
PrintDisplayed: 12/7/2024 06:26